A citation-based method for searching scientific literature

M J Vijay Kumar, Devanshi Shah, Mridhula Giridharan, Niraj Yadav, Ravi Manjithaya, James P Clement. Sci Rep 2021
Times Cited: 5







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.
Claudia Rose, Fiona M Menzies, Maurizio Renna, Abraham Acevedo-Arozena, Silvia Corrochano, Oana Sadiq, Steve D Brown, David C Rubinsztein. Hum Mol Genet 2010
144
40

Repurposing of FDA-approved drugs as autophagy inhibitors in tumor cells.
Kumari Prerna, Vikash Kumar Dubey. J Biomol Struct Dyn 2022
4
50

Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation.
Hui-Chuan Yu, Chen-Si Lin, Wei-Tien Tai, Chun-Yu Liu, Chung-Wai Shiau, Kuen-Feng Chen. J Biol Chem 2013
71
40

Nilotinib, A Tyrosine Kinase Inhibitor, Suppresses the Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer.
Lei Meng, Pengxin Zhao, Zhigang Hu, Weiyuan Ma, Yong Niu, Jingwei Su, Yubo Zhang. Anticancer Agents Med Chem 2022
4
50


Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance.
Irina Lonskaya, Michaeline L Hebron, Nicole M Desforges, Joel B Schachter, Charbel E-H Moussa. J Mol Med (Berl) 2014
97
40


Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
Alexander V Panov, Claire-Anne Gutekunst, Blair R Leavitt, Michael R Hayden, James R Burke, Warren J Strittmatter, J Timothy Greenamyre. Nat Neurosci 2002
757
40

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
40


Anterograde transport of brain-derived neurotrophic factor and its role in the brain.
C A Altar, N Cai, T Bliven, M Juhasz, J M Conner, A L Acheson, R M Lindsay, S J Wiegand. Nature 1997
691
40

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
40

The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.
Constanza J Cortes, Albert R La Spada. Drug Discov Today 2014
77
40

Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity.
F M Menzies, M Garcia-Arencibia, S Imarisio, N C O'Sullivan, T Ricketts, B A Kent, M V Rao, W Lam, Z W Green-Thompson, R A Nixon,[...]. Cell Death Differ 2015
75
40

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
767
40

Autophagy as a promoter of longevity: insights from model organisms.
Malene Hansen, David C Rubinsztein, David W Walker. Nat Rev Mol Cell Biol 2018
314
40

Deep brain stimulation in Huntington's disease: A 4-year follow-up case report.
Sabine Spielberger, Anna Hotter, Elisabeth Wolf, Wilhelm Eisner, Jörg Müller, Werner Poewe, Klaus Seppi. Mov Disord 2012
23
20


Epigenetics of Huntington's Disease.
Silvia Bassi, Takshashila Tripathi, Alan Monziani, Francesca Di Leva, Marta Biagioli. Adv Exp Med Biol 2017
31
20

Extending the Phenotypic Spectrum of Huntington Disease: Hypothermia.
Şule Altıner, Senol Ardic, Alper H Çebi. Mol Syndromol 2020
1
100

Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.
Sandra M Holley, Talia Kamdjou, Jack C Reidling, Brian Fury, Dane Coleal-Bergum, Gerhard Bauer, Leslie M Thompson, Michael S Levine, Carlos Cepeda. CNS Neurosci Ther 2018
11
20

Characterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of Huntington's Disease.
Lindsay Dodds, Jianfang Chen, Kiersten Berggren, Jonathan Fox. PLoS Curr 2014
14
20


Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.
Tara L Spires, Helen E Grote, Neelash K Varshney, Patricia M Cordery, Anton van Dellen, Colin Blakemore, Anthony J Hannan. J Neurosci 2004
282
20

The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
Haiqun Jia, Ying Wang, Charles D Morris, Vincent Jacques, Joel M Gottesfeld, James R Rusche, Elizabeth A Thomas. PLoS One 2016
55
20

α-Synuclein levels modulate Huntington's disease in mice.
Silvia Corrochano, Maurizio Renna, Sarah Carter, Nichola Chrobot, Rose Kent, Michelle Stewart, Jason Cooper, Steve D M Brown, David C Rubinsztein, Abraham Acevedo-Arozena. Hum Mol Genet 2012
32
20

Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Jonathan H Fox, David S Barber, Bhupinder Singh, Birgit Zucker, Mary K Swindell, Fran Norflus, Rodica Buzescu, Raman Chopra, Robert J Ferrante, Aleksey Kazantsev,[...]. J Neurochem 2004
110
20

Risperidone in chorea and psychosis of Huntington's disease.
A Kemal Erdemoglu, C Boratav. Eur J Neurol 2002
35
20

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.
Wenzhen Duan, Zhihong Guo, Haiyang Jiang, Melvin Ware, Xiao-Jiang Li, Mark P Mattson. Proc Natl Acad Sci U S A 2003
319
20

Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
Chiung-Mei Chen, Yih-Ru Wu, Mei-Ling Cheng, Jun-Liang Liu, Yu-May Lee, Po-Wei Lee, Bing-Wen Soong, Daniel Tsun-Yee Chiu. Biochem Biophys Res Commun 2007
160
20


Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
N Cabezas-Llobet, L Vidal-Sancho, M Masana, A Fournier, J Alberch, D Vaudry, X Xifró. Mol Neurobiol 2018
29
20

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
Jinho Kim, Jennifer P Moody, Christina K Edgerly, Olivia L Bordiuk, Kerry Cormier, Karen Smith, M Flint Beal, Robert J Ferrante. Hum Mol Genet 2010
223
20


AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease.
J Miniarikova, V Zimmer, R Martier, C C Brouwers, C Pythoud, K Richetin, M Rey, J Lubelski, M M Evers, S J van Deventer,[...]. Gene Ther 2017
50
20

Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.
Robert Schwarcz, Paolo Guidetti, Korrapati V Sathyasaikumar, Paul J Muchowski. Prog Neurobiol 2010
120
20

Metformin intake associates with better cognitive function in patients with Huntington's disease.
David Hervás, Victoria Fornés-Ferrer, Ana Pilar Gómez-Escribano, María Dolores Sequedo, Carmen Peiró, José María Millán, Rafael P Vázquez-Manrique. PLoS One 2017
44
20

Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin.
Edith L Pfister, Kathryn O Chase, Huaming Sun, Lori A Kennington, Faith Conroy, Emily Johnson, Rachael Miller, Florie Borel, Neil Aronin, Christian Mueller. Mol Ther Nucleic Acids 2017
19
20

Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease.
Calum D Moulton, C W P Hopkins, W Richard Bevan-Jones. Mov Disord 2014
32
20

An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
Benjamin R Underwood, Zeyn W Green-Thompson, Peter J Pugh, Stanley E Lazic, Sarah L Mason, Jules Griffin, P Simon Jones, James B Rowe, David C Rubinsztein, Roger A Barker. J Neurol 2017
16
20


Treadmill exercise improves short-term memory by enhancing hippocampal cell proliferation in quinolinic acid-induced Huntington's disease rats.
You-Mi Kim, Eun-Sang Ji, Sang-Hoon Kim, Tae-Woon Kim, Il-Gyu Ko, Jun-Jang Jin, Chang-Ju Kim, Tae-Wook Kim, Dong-Hee Kim. J Exerc Rehabil 2015
19
20

Olanzapine in Huntington's disease.
D Paleacu, M Anca, N Giladi. Acta Neurol Scand 2002
53
20


Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Han Seok Ko, Yunjong Lee, Joo-Ho Shin, Senthilkumar S Karuppagounder, Bharathi Shrikanth Gadad, Anthony J Koleske, Olga Pletnikova, Juan C Troncoso, Valina L Dawson, Ted M Dawson. Proc Natl Acad Sci U S A 2010
199
20


Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model.
Wenxiao Jiang, Wenjie Wei, Marta A Gaertig, Shihua Li, Xiao-Jiang Li. PLoS One 2015
54
20

Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.
Carmela Giampà, Alessandra Alvino, Marta Magatti, Antonietta R Silini, Antonella Cardinale, Emanuela Paldino, Francesca R Fusco, Ornella Parolini. J Cell Mol Med 2019
25
20

Mouse Models of Huntington's Disease.
Pamela P Farshim, Gillian P Bates. Methods Mol Biol 2018
35
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.